Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane

Journal of Nutrition

Volumn 135, Issue 8, 2005, Pages 1865-1872

  Traka, Maria ^a   Gasper, Amy V ^a   Smith, Julie A ^b   Hawkey, Chris J ^b   Bao, Yongping ^a,c   Mithen, Richard F ^a  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

AMACR; Chemoprevention; Colon cancer; KLF4; Microarray; p21; Sulforaphane

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; DNA METHYLTRANSFERASE 1; KRUPPEL LIKE FACTOR 4; PROTEIN P21; SULFORAPHANE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BROCCOLI; CANCER RISK; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN CACO 2; COLON CANCER; CONTROLLED STUDY; DNA METHYLATION; FATTY ACID METABOLISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; RNA ANALYSIS; XENOBIOTIC METABOLISM;

BRASSICA OLERACEA VAR. BOTRYTIS;

EID: 23244450241     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.8.1865     Document Type: Article

References (70)

1. Ambrosone, C. B., McCann, S. E., Freudenheim, J. L., Marshall, J. R., Zhang, Y. & Shields, P. G. (2004) Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J. Nutr. 134: 1134-1138.
2. Fowke, J. H., Chung, F. L., Jin, F., Qi, D., Cai, Q., Conaway, C., Cheng, J. R., Shu, X. O., Gao, Y. T. & Zheng, W. (2003) Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res. 63: 3980-3986.
3. Joseph, M. A., Moysich, K. B., Freudenheim, J. L., Shields, P. G., Bowman, E. D., Zhang, Y., Marshall, J. R. & Ambrosone, C. B. (2004) Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr. Cancer 50: 206-213.
4. London, S. J., Yuan, J. M., Chung, F. L., Gao, Y. T., Coetzee, G. A., Ross, R. K. & Yu, M. C. (2000) Isothiocyanates, glutathione S-transferass M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 356: 724-729.
5. Seow, A., Yuan, J. M., Sun, C. L., Van den Berg, D., Lee, H. P. & Yu, M. C. (2002) Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis 23: 2055-2061.
6. Lin, H. J., Probst-Hensch, N. M., Louie, A. D., Kau, I. H., Witte, J. S., Ingles, S. A., Frankl, H. D., Lee, E. R. & Haile, R. W. (1998) Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomark. Prev. 7: 647-652.
7. Conaway, C. C., Getahun, S. M., Liebes, L. L., Pusateri, D. J., Topham, D. K., Botero-Omary, M. & Chung, F. L. (2000) Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer 38: 168-178.
8. Getahun, S. M. & Chung, F. L. (1999) Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol. Biomark. Prev. 8: 447-451.
9. Ye, L., Dinkova-Kostova, A. T., Wade, K. L., Zhang, Y., Shapiro, T. A. & Talalay, P. (2002) Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin. Chim. Acta 316: 43-53.
10. Fimognari, C., Nusse, M., Berti, F., Iori, R., Cantelli-Forti, G. & Hrelia, P. (2002) Cyclin D3 and p53 mediate sulforaphane-induced cell cycle delay and apoptosis in non-transformed human T lymphocytes. Cell Mol. Life Sci. 59: 2004-2012.
11. Chiao, J. W., Chung, F. L., Kancherla, R., Ahmed, T., Mittelman, A. & Conaway, C. C. (2002) Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int. J. Oncol. 20: 631-636.
12. Wang, L., Liu, D., Ahmed, T., Chung, F. L., Conaway, C. & Chiao, J. W. (2004) Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int. J. Oncol. 24: 187-192.
13. Fimognari, C., Nusse, M., Cesari, R., Iori, R., Cantelli-Forti, G. & Hrelia, P. (2002) Growth inhibition, cell-cycle arrest and apoptosis in human T- cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis 23: 581-586.
14. Gamet-Payrastre, L., Li, P., Lumeau, S., Cassar, G., Dupont, M. A., Chevolleau, S., Gasc, N., Tulliez, J. & Terce, F. (2000) Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 60: 1426-1433.
15. Jackson, S. J. & Singletary, K. W. (2004) Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 25: 219-227.
16. Bonnesen, C., Eggleston, I. M. & Hayes, J. D. (2001) Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res. 61: 6120-6130.
17. Kim, B. R., Hu, R., Keum, Y. S., Hebbar, V., Shen, G., Nair, S. S. & Kong, A. N. (2003) Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res. 63: 7520-7525.
18. Chen, Y. R., Wang, W., Kong, A. N. & Tan, T. H. (1998) Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. J. Biol. Chem. 273: 1769-1775.
19. Hu, R., Kim, B. R., Chen, C., Hebbar, V. & Kong, A. N. (2003) The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 24: 1361-1367.
20. Parnaud, G., Li, P., Cassar, G., Rouimi, P., Tulliez, J., Combaret, L. & Gamet-Payrastre, L. (2004) Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr. Cancer 48: 198-206.
21. Vistica, D. T., Skehan, P., Scudiero, D., Monks, A., Pittman, A. & Boyd, M. R. (1991) Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 51: 2515-2520.
22. Affymetrix, I. O. (2004) Statistical Algorithms Description Document. http://www.affymetrix.com/support/downloads/manual s/ data_analysis_fundamentals_manual.pdf [accessed Jan. 25, 2004].
23. Li, C. & Wong, W. H. (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U.S.A. 98: 31-36.
24. Han, E. S., Wu, Y., McCarter, R., Nelson, J. F., Richardson, A. & Hilsenbeck, S. G. (2004) Reproducibility, sources of variability, pooling, and sample size: important considerations for the design of high-density oligonucleotide array experiments. J. Gerontol. A Biol. Sci. Med. Sci. 59: 306-315.
25. R Development Core Team (2004) R: a language and environment for statistical computing. http://www.R-project.org. [accessed Dec 10, 2004].
26. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25: 25-29.
27. The Gene Ontology http://www.geneontology.org [accessed Dec 10, 2004].
28. Gingras, D., Gendron, M., Boivin, D., Moghrabi, A., Theoret, Y. & Beliveau, R. (2004) Induction of medulloblastoma cell apoptosis by sulforaphane, a dietary anticarcinogen from Brassica vegetables. Cancer Lett. 203: 35-43.
29. Yuen, T., Wurmbach, E., Pfeffer, R. L., Ebersole, B. J. & Sealfon, S. C. (2002) Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 30: e48.
30. Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A. & Anand-Apte, B. (2003) A novel function for tissue inhibitor of mstalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9: 407-415.
31. Baek, S. J., Kim, J. S., Jackson, F. R., Eling, T. E., McEntee, M. F. & Lee, S. H. (2004) Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis 25: 2425-2432.
32. Wilson, L. C., Baek, S. J., Call, A. & Eling, T. E. (2003) Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int. J. Cancer 105: 747-753.
33. Misiewicz, I., Skupinska, K. & Kasprzycka-Guttman, T. (2003) Sulforaphane and 2-oxohexyl isothiocyanate induce cell growth arrest and apoptosis in L-1210 leukemia and ME-18 melanoma cells. Oncol. Rep. 10: 2045-2050.
34. Singh, A. V., Xiao, D., Lew, K. L., Dhir, R. & Singh, S. V. (2004) Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 25: 83-90.
35. Chen, Y. R., Han, J., Kori, R., Kong, A. N. & Tan, T. H. (2002) Phenylethyl isothiocyanate induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-terminal kinase. J. Biol. Chem. 277: 39334-39342.
36. Xu, K. & Thornalley, P. J. (2001) Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK. Br. J. Cancer 84: 670-673.
37. Yu, R., Jiao, J. J., Duh, J. L., Tan, T. H. & Kong, A. N. (1996) Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1. Cancer Res. 56: 2954-2959.
38. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R. & Franzoso, G. (2001) Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature (Lond.) 414: 308-313.
39. Nakagomi, S., Suzuki, Y., Namikawa, K., Kiryu-Seo, S. & Kiyama, H. (2003) Expression of the activating transcription factor 3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and Akt activation. J. Neurosci. 23: 5187-5196.
40. Chauhan, D., Li, G., Hideshima, T., Podar, K., Mitsiades, C., Mitsiades, N., Catley, L., Tai, Y. T., Hayashi, T. et al. (2003) Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance. Blood 102: 3379-3386.
41. Concannon, C. G., Gorman, A. M. & Samali, A. (2003) On the role of Hsp27 in regulating apoptosis. Apoptosis 8: 61-70.
42. Liu, Z. M., Chen, G. G., Ng, E. K., Leung, W. K., Sung, J. J. & Chung, S. C. (2004) Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene 23: 503-513.
43. Brooks, J. D., Paton, V. G. & Vidanes, G. (2001) Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol. Biomark. Prev. 10: 949-954.
44. Hintze, K. J., Keck, A. S., Finley, J. W. & Jeffery, E. H. (2003) Induction of hepatic thioredoxin reductase activity by sulforaphane, both in Hepa1c1c7 cells and in male Fisher 344 rats. J. Nutr. Biochem. 14: 173-179.
45. Zhang, J., Svehlikova, V., Bao, Y., Howie, A. F., Beckett, G. J. & Williamson, G. (2003) Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. Carcinogenesis 24: 497-503.
46. Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M. & Biswal, S. (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62: 5196-5203.
47. Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M. & Talalay, P. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 99: 11908-11913.
48. McMahon, M., Itoh, K., Yamamoto, M. & Hayes, J. D. (2003) Keap1-dependent proteasomai degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278: 21592-21600.
49. Kwak, M. K., Egner, P. A., Dolan, P. M., Ramos-Gomez, M., Groopman, J. D., Itoh, K., Yamamoto, M. & Kensler, T. W. (2001) Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat. Res. 480-481: 305-315.
50. Vairapandi, M., Balliet, A. G., Fornace, A. J., Jr., Hoffman, B. & Liebermann, D. A. (1996) The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and P21WAF1/CIP1. Oncogene 12: 2579-2594.
51. Kaul, R., Mukherjee, S., Ahmed, F., Bhat, M. K., Chhipa, R., Galande, S. & Chattopadhyay, S. (2003) Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice. Int. J. Cancer 103: 606-615.
52. Corrente, G., Guardavaccaro, D. & Tirone, F. (2002) PC3 potentiates NGF-induced differentiation and protects neurons from apoptosis. Neuroreport 13: 417-422.
53. Egan, E. A. & Solomon, M. J. (1998) Cyclin-stimulated binding of Cks proteins to cyclin-dependent kinases. Mol. Cell Biol. 18: 3659-3667.
54. Lindner, K., Gregan, J., Montgomery, S. & Kearsey, S. E. (2002) Essential role of MCM proteins in premeiotic DNA replication. Mol. Biol. Cell 13: 435-444.
55. Shie, J. L., Chen, Z. Y., O'Brien, M. J., Pestell, R. G., Lee, M. E. & Tseng, C. C. (2000) Role of gut-enriched Kruppel-like factor in colonic cell growth and differentiation. Am. J. Physiol. 279: G806-G814.
56. Shields, J. M., Christy, R. J. & Yang, V. W. (1996) Identiflcat on and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J. Biol. Chem. 271: 20009-20017.
57. Conkright, M. D., Wani, M. A., Anderson, K. P. & Lingrel, J. B. (1999) A gene encoding an intestinal-enriched member of the Kruppel-like factor family expressed in intestinal epithelial cells. Nucleic Acids Res. 27: 1263-1270.
58. Chen, X., Johns, D. C., Geiman, D. E., Marban, E., Dang, D. T., Hamlin, G., Sun, R. & Yang, V. W. (2001) Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 276: 30423-30428.
59. Chen, X., Whitney, E. M., Gao, S. Y. & Yang, V. W. (2003) Transcriptional profiling of Kruppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J. Mol. Biol. 326: 665-677.
60. Dang, D. T., Chen, X., Feng, J., Torbenson, M., Dang, L. H. & Yang, V. W. (2003) Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene 22: 3424-3430.
61. Dang, D. T., Mahatan, C. S., Dang, L. H., Agboola, I. A. & Yang, V. W. (2001) Expression of the gut-enriched Kruppel-like factor (Kruppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene 20: 4884-4890.
62. Stone, C. D., Chen, Z. Y. & Tseng, C. C. (2002) Gut-enriched Kruppel-like factor regulates colonie cell growth through APC/beta-catenin patiway. FEES Lett. 530: 147-152.
63. Ton-That, H., Kaestner, K. H., Shields, J. M., Mahatanankoon, C. S. & Yang, V. W. (1997) Expression of the gut-enriched Kruppel-like factor gene during development and intestinal tumorigenesis. FEES Lett. 419: 239-243.
64. Ichii, S., Horii, A., Nakatsuru, S., Furuyama, J., Utsunomiya, J. & Uakamura, Y. (1992) Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP). Hum. Mol. Genet. 1: 387-390,
65. Dang, D. T., Bachman, K. E., Mahatan, C. S., Dang, L. H., Giardiello, F. M. & Yang, V. W. (2000) Decreased expression of the gut-enriched Kruppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEES Lett. 476: 203-207.
66. Chen, L. C., Hao, C. Y., Chiu, Y. S., Wong, P., Melnick, J. S., Brotmar., M., Moretto, J., Mendes, F., Smith, A. P. et al. (2004) Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res. 64: 3694-3700.
67. Jiang, Z., Wu, C. L., Woda, B. A., Iczkowski, K. A., Chu, P. G., Tretiakova, M. S., Young, R. H., Weiss, L. M., Blute, R. D., Jr. et al. (2004) Alpha-Methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology 45: 218-225.
68. Wu, C. L., Yang, X. J., Tretiakova, M., Patton, K. T., Halpern, E. F., Woda, B. A., Young, R. H. & Jiang, Z. (2004) Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum. Pathol. 35: 1008-1013.
69. Zhou, M., Chinnaiyan, A. M., Kleer, C. G., Lucas, P. C. & Rubin, M. A. (2002) α-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am. J. Surg. Pathol. 26: 926-931.
70. Jiang, Z., Fanger, G. R., Banner, B. F., Woda, B. A., Algate, P., Dresser, K., Xu, J., Reed, S. G., Rock, K. L. & Chu, P. G. (2003) A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect. Prev. 27: 422-426.